← SynDRA
SNX-2112
SynDRA canonical compound SYN0019337 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Mechanism of action | HSP inhibitor |
All known targets
Mechanisms of action (all sources)
- HSP inhibitor
- HSP90AA1 INHIBITOR
- Heat shock protein HSP90 inhibitor
- HSP90AB1 INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- HDAC6
- HSP90AB1
- HSP90B1
- TRAP1
Cross-references
Synonyms
- PF-04928473
- SNX 2112
- 4-(6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)-2-((1r,4r)-4-hydroxycyclohexylamino)benzamide
- UNII-10C9P3FFOW
- 10C9P3FFOW
- CHEMBL560895
- SNX-2112 (PF-04928473)
- 4-[6,6-dimethyl-4-oxo-3-(trifluoromethyl)-5,7-dihydroindazol-1-yl]-2-[(4-hydroxycyclohexyl)amino]benzamide
- 4-[6,6-Dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]-2-[(cis-4-hydroxycyclohexyl)amino]benzamide
- SW219742-1
- NCGC00346633-01
- FS103989
- C77089
- AC-36048
- E0G
- CHEBI:231695
- AS-75100
- SMR004702870
- BRD-K71281111-001-01-9
- SNX-2112(PF-04928473)
- EX-A2375
- MFCD28978131
- NCGC00386182-02
- MLS006011082
- ZFVRYNYOPQZKDG-XBXGTLAGSA-N
- CCG-269392
- DA-77906
- 4nh7
- SNX2112
- BDBM50450704
- SCHEMBL1219380
- SCHEMBL1219382
- AKOS027270068
- SB19446
- SCHEMBL1221195
- EBC-157218
- MFCD16038907
Look up SNX-2112 in the interactive SynDRA portal →